...
首页> 外文期刊>Seminars in cutaneous medicine and surgery. >New Horizons in Treating Disorders of Hyperpigmentation in Skin of Color
【24h】

New Horizons in Treating Disorders of Hyperpigmentation in Skin of Color

机译:治疗有色皮肤色素沉着过度症的新视野

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Pigmentary abnormalities are among the most common reasons why patients with skin of color visit a dermatologist. Hydroquinone has been a cornerstone for the treatment of hyperpigmentation; however, concerns regarding adverse effects have prompted a search for alternative agents. Some promising topical treatments include soy, licorice, rucinol, mulberry, niacinamide, ellagic acid, resveratrol, and dioic acid. Oral agents, primarily used for the prevention of postprocedural hyperpigmentation, include procyanidins, tranexamic acid, and Polypodium leucotomos. Advances in Q-switched lasers, intense pulse light, fractional photothermolysis, and the advent of tretinoin peeling add to the clinician's armamentarium for treating hyperpigmentation.
机译:色素异常是有色皮肤患者拜访皮肤科医生的最常见原因之一。对苯二酚一直是色素沉着过度治疗的基石。但是,有关不良反应的担忧促使人们寻找替代药物。一些有希望的局部治疗方法包括大豆,甘草,芸香醇,桑树,烟酰胺,鞣花酸,白藜芦醇和二酸。主要用于预防过程后色素沉着的口服药物包括原花青素,氨甲环酸和白粉病。调Q激光器,强脉冲光,部分光热分解以及维甲酸脱皮的出现,为临床医生治疗过度色素沉着提供了便利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号